These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26695364)

  • 1. Effect of the Gut Microbiota on Obesity and Its Underlying Mechanisms: an Update.
    Qian LL; Li HT; Zhang L; Fang QC; Jia WP
    Biomed Environ Sci; 2015 Nov; 28(11):839-47. PubMed ID: 26695364
    [No Abstract]   [Full Text] [Related]  

  • 2. The Gut Microbiome and Probiotics.
    Fatima A; Sylvester FA
    Adolesc Med State Art Rev; 2016; 27(1):140-54. PubMed ID: 27363238
    [No Abstract]   [Full Text] [Related]  

  • 3. An overview of microbiome based strategies on anti-obesity.
    Chang CS; Ruan JW; Kao CY
    Kaohsiung J Med Sci; 2019 Jan; 35(1):7-16. PubMed ID: 30844145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Microbiota and Energy Expenditure in Health and Obesity.
    Bakker GJ; Zhao J; Herrema H; Nieuwdorp M
    J Clin Gastroenterol; 2015; 49 Suppl 1():S13-9. PubMed ID: 26447957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Gut Microbiota: The Gateway to Improved Metabolism.
    Martinez KB; Pierre JF; Chang EB
    Gastroenterol Clin North Am; 2016 Dec; 45(4):601-614. PubMed ID: 27837775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota: a target for intervention in obesity.
    Sehgal K; Khanna S
    Expert Rev Gastroenterol Hepatol; 2021 Oct; 15(10):1169-1179. PubMed ID: 34329563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota and type 2 diabetes mellitus.
    Muñoz-Garach A; Diaz-Perdigones C; Tinahones FJ
    Endocrinol Nutr; 2016 Dec; 63(10):560-568. PubMed ID: 27633134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The New Era of Treatment for Obesity and Metabolic Disorders: Evidence and Expectations for Gut Microbiome Transplantation.
    Jayasinghe TN; Chiavaroli V; Holland DJ; Cutfield WS; O'Sullivan JM
    Front Cell Infect Microbiol; 2016; 6():15. PubMed ID: 26925392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk.
    Miele L; Giorgio V; Alberelli MA; De Candia E; Gasbarrini A; Grieco A
    Curr Cardiol Rep; 2015 Dec; 17(12):120. PubMed ID: 26497040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the Gut Microbiome in the Pathogenesis of Obesity and Obesity-Related Metabolic Dysfunction.
    Bouter KE; van Raalte DH; Groen AK; Nieuwdorp M
    Gastroenterology; 2017 May; 152(7):1671-1678. PubMed ID: 28192102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Gut Microbiome and Obesity.
    John GK; Mullin GE
    Curr Oncol Rep; 2016 Jul; 18(7):45. PubMed ID: 27255389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?
    Esteve E; Ricart W; Fernández-Real JM
    Curr Opin Clin Nutr Metab Care; 2011 Sep; 14(5):483-90. PubMed ID: 21681087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota: a key player in health and disease. A review focused on obesity.
    Villanueva-Millán MJ; Pérez-Matute P; Oteo JA
    J Physiol Biochem; 2015 Sep; 71(3):509-25. PubMed ID: 25749935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting gut microbiota as a possible therapy for diabetes.
    He C; Shan Y; Song W
    Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges in fecal donor selection and screening for fecal microbiota transplantation: A review.
    Woodworth MH; Carpentieri C; Sitchenko KL; Kraft CS
    Gut Microbes; 2017 May; 8(3):225-237. PubMed ID: 28129018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Microbiome in Obesity, Metabolic Syndrome, and Diabetes.
    Chen X; Devaraj S
    Curr Diab Rep; 2018 Oct; 18(12):129. PubMed ID: 30338410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
    Vemuri RC; Gundamaraju R; Shinde T; Eri R
    Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diet-induced obesity, gut microbiota and bone, including alveolar bone loss.
    Eaimworawuthikul S; Thiennimitr P; Chattipakorn N; Chattipakorn SC
    Arch Oral Biol; 2017 Jun; 78():65-81. PubMed ID: 28213172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probiotics, prebiotics, energy balance, and obesity: mechanistic insights and therapeutic implications.
    Molinaro F; Paschetta E; Cassader M; Gambino R; Musso G
    Gastroenterol Clin North Am; 2012 Dec; 41(4):843-54. PubMed ID: 23101690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.